Agenus (AGEN) director Armen takes June 2026 salary in 5,364 company shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
ARMEN GARO H reported acquisition or exercise transactions in this Form 4 filing.
Agenus Inc. director and officer Dr. Garo H. Armen received company stock as salary instead of cash for the pay period ending June 26, 2026. He was granted 5,364 shares of common stock, representing the net amount of his salary, at a reference price of $3.03 per share, which was the closing price on June 26, 2026. These shares were issued under the Amended and Restated Agenus Inc. 2019 Equity Incentive plan and were fully vested on the date of issuance, bringing his directly held common stock to 366,256 shares. The filing also notes indirect holdings through IRA accounts and through entities such as the Garo Armen 2020 2 Year AG GRAT with 23,950 shares and the Pixie Partners general partnership with 5,000 shares, where he has only a partial pecuniary interest in the partnership’s shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
ARMEN GARO H
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 5,364 | $3.03 | $16K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 366,256 shares (Direct, null);
Common Stock — 31,298 shares (Indirect, See Footnote)
Footnotes (1)
- At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending June 26th, 2026. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance. $3.03 is the closing price of our Common Stock on June 26th, 2026, the last trading day for the payroll date for the pay period ending June 26th, 2026. Shares are held in Dr. Armen's IRA accounts. Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.
Key Figures
Stock salary grant: 5,364 shares
Reference share price: $3.03 per share
Direct holdings after grant: 366,256 shares
+2 more
5 metrics
Stock salary grant
5,364 shares
Net salary for pay period ending June 26, 2026
Reference share price
$3.03 per share
Closing price on June 26, 2026 used for salary stock
Direct holdings after grant
366,256 shares
Common stock directly held by Dr. Armen post-transaction
GRAT holdings
23,950 shares
Shares held by Garo Armen 2020 2 Year AG GRAT
Pixie Partners holdings
5,000 shares
Shares held by Pixie Partners where Armen has partial pecuniary interest
Key Terms
Equity Incentive, IRA accounts, GRAT, pecuniary interest, +1 more
5 terms
Equity Incentive financial
"Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive"
Equity incentive is a form of pay that gives employees or executives a stake in the company through stock or the right to buy stock, often granted with conditions that spread out over time. It matters to investors because it aligns workers’ interests with shareholders—encouraging growth and retention—but can also affect share count and profits when new shares are issued, similar to giving team members a slice of the company pie that can grow or dilute others’ slices.
IRA accounts financial
"Shares are held in Dr. Armen's IRA accounts."
An IRA account is a tax-advantaged personal savings account designed to help people invest for retirement; think of it as a special piggy bank that gives you tax breaks to encourage long-term saving. Different IRA types change when you pay taxes and when you can take money out, so they matter to investors because the choice affects your after-tax returns, portfolio decisions, and the timing of withdrawals during retirement.
GRAT financial
"Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock."
pecuniary interest financial
"Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie"
beneficial ownership financial
"and disclaims beneficial ownership to the extent of his pecuniary interest therein."
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
What insider transaction did Agenus (AGEN) report for Dr. Garo H. Armen?
Dr. Garo H. Armen received 5,364 Agenus common shares as salary instead of cash. The grant reflects his net salary for the pay period ending June 26, 2026 and was fully vested upon issuance under the company’s 2019 Equity Incentive plan.
How is Dr. Armen’s salary structured according to the Agenus (AGEN) Form 4 footnotes?
At his request and with compensation committee approval, Dr. Armen’s salary is being paid in Agenus stock instead of cash. The Form 4 shows the net number of shares issued for the pay period, fully vested on issuance, under the 2019 Equity Incentive plan.
Does the Agenus (AGEN) Form 4 indicate open-market buying or selling by Dr. Armen?
No open-market purchases or sales are reported. The primary transaction is a stock grant for 5,364 shares as compensation. Additional entries reflect indirect holdings, such as IRA accounts and entity-held shares, rather than market trades by Dr. Armen.